Anna Riccio

Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer

Michele Cioffi, Crescenzo D’Alterio, Rosa Camerlingo et al. · Scientific Reports · 2015 · 106 citations · Full text

Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases

Luigi Portella, Rosa Maria Vitale, Stefania De Luca et al. · PLoS ONE · 2013 · 85 citations · Full text

Peptides R, Preclinical Development, New Cxcr4 +15

CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells

Caterina Ieranò, Sara Santagata, Maria Napolitano et al. · Cell Death and Disease · 2014 · 79 citations · Full text

OA 17.06 Updated Analysis of KEYNOTE-024: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC With PD-L1 TPS ≥50%

Julie R. Brahmer, Delvys Rodríguez‐Abreu, Andrew Robinson et al. · Journal of Thoracic Oncology · 2017 · 70 citations

Advanced Nsclc, Medicine, Pharmacology +11

Functional characterization of an ammonium transporter gene from Lotus japonicus

Francesca Salvemini, Anne‐Marie Marini, Anna Riccio et al. · Gene · 2001 · 69 citations

Biology, Plant Biology, Plant Molecular Biology +8